New Medicaid Bulletins Available as of May 3, 2022

The NC Division of Health Benefits (DHB) has recently published new Medicaid Bulletin articles:

  • Sutimlimab-jome Injection, for Intravenous Use (Enjaymo™) HCPCS Code J3590: Billing Guidelines
  • One Year Anniversary of New Service to Ensure Communication Access in Health Care Settings
  • Nivolumab and Relatlimab-rmbw Injection, for Intravenous Use (Opdualag™) HCPCS Code J9999: Billing Guidelines
  • Filgrastim-ayow Injection, for Subcutaneous or Intravenous Use (Releuko®) HCPCS Code J3590: Billing Guidelines
  • Ephedrine Hydrochloride Injection, for Intravenous use (Rezipres®) HCPCS code J3490: Billing Guidelines
  • Difelikefalin Injection, for Intravenous use (Korsuva™) HCPCS code J0879 - Injection, difelikefalin, 0.1 microgram, (for ESRD on Dialysis): Billing Guidelines
  • Healthy Opportunities Housing and Transportation Services Available

Providers are encouraged to review this information. All bulletin articles, including those related to COVID-19, are available on DHB's Medicaid Bulletin webpage.